Human Cytomegalovirus Glycoprotein UL141 Targets the TRAIL Death Receptors to Thwart Host Innate Antiviral Defenses

Wendell Smith; Peter Tomasec; Rebecca Aicheler; Andrea Loewendorf; Ivana Nemčovičová; Eddie C.Y. Wang; Richard J. Stanton; Matt Macauley; Paula Norris; Laure Willen; Eva Ruckova; Akio Nomoto; Pascal Schneider; Gabriele Hahn; Dirk M. Zajonc; Carl F. Ware; Gavin W.G. Wilkinson; Chris A. Benedict; Andrews; Ashiru; Ashkenazi; Baillie; Baryawno; Benedict; Benedict; Benedict; Bodmer; Bodmer; Bossen; Cha; Chalupny; Chen; Cheung; Cobbs; Cummins; Diehl; Dziurzynski; Emery; Feng; Gatherer; Hahn; Hahn; Hallett; Hansen; Jarvis; Le; Leithner; Loewendorf; Loureiro; McCormick; McSharry; Mocarski; Montag; Murphy; Nigro; Poli; Prod’homme; Prod’homme; Raftery; Rahman; Sato; Schleiss; Schneider; Schneider; Sedger; Sedy; Sedý; Simanek; Skaletskaya; Skaletskaya; Smyth; Söderberg-Nauclér; Stanton; Streblow; Takeda; Tomasec; Tomasec; Truneh; Wang; Wilkinson; Xu; Yu; Zhang

Human Cytomegalovirus Glycoprotein UL141 Targets the TRAIL Death Receptors to Thwart Host Innate Antiviral Defenses

Abstract

Abstract is not available.

Similar works

Full text

Crossref

Full text is not available

Last time updated on 2/18/2019

This paper was published in Crossref.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.